E Fund Management’s BioNTech BNTX Stock Holding History

E Fund Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-21,300	Closed	-$1.94M	–	405
2025 Q1	$1.94M	Buy	+21,300	New	+$2.38M	0.09%	117

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

E Fund Management's BNTX Position: Q2 2025 in Review

E Fund Management sold out of BioNTech (BNTX) in Q2 2025, closing a stake of 21,300 shares — an estimated $1.94M sold.

E Fund Management first reported a position in BNTX in Q1 2025 and held it in 1 quarter. The position peaked at $1.94M in Q1 2025. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

E Fund Management reported no remaining BioNTech position as of Q2 2025 after selling out during the quarter.
E Fund Management sold 21,300 BioNTech shares in Q2 2025, an estimated $1.94M.
E Fund Management first reported a position in BioNTech in Q1 2025 and held it in 1 quarter.
E Fund Management's BioNTech position peaked at $1.94M in Q1 2025.
258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on E Fund Management's 13F filing for Q2 2025, filed 15 Aug 2025.